AJP - GI Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 288: G1301-G1309, 2005; doi:10.1152/ajpgi.00399.2004
0193-1857/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ship, N. J.
Right arrow Articles by Pang, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ship, N. J.
Right arrow Articles by Pang, K. S.

LIVER AND BILIARY TRACT

Binding of acellular, native and cross-linked human hemoglobins to haptoglobin: enhanced distribution and clearance in the rat

Noam J. Ship,1 Ayça Toprak,2 Roseanna P. Lai,1 Eric Tseng,2 Ronald Kluger,1 and K. Sandy Pang2

1Davenport Laboratory, Department of Chemistry, and 2Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada

Submitted 1 September 2004 ; accepted in final form 2 December 2004

It is well established that hemoglobin resulting from red cell lysis binds to haptoglobin in plasma to form a complex. The increased molecular size precludes its filtration by the kidneys, redirecting it toward hepatocellular entry. Chemically cross-linked hemoglobins are designed to be resistant to renal excretion, even in the absence of haptoglobin. The manner in which binding to haptoglobin influences the pharmacokinetics of acellular cross-linked and native hemoglobins was investigated after intravenous injection of radiolabeled native human hemoglobin and trimesyl-(Lys82){beta}-(Lys82){beta} cross-linked human hemoglobin, at trace doses, into rats. Under these conditions, there is sufficient plasma haptoglobin for binding with hemoglobin. In vitro binding assayed by size-exclusion chromatography for bound and free hemoglobin revealed that, at <8 µM hemoglobin, native human hemoglobin was completely bound to rat haptoglobin, whereas only ~30% of trimesyl-(Lys82){beta}-(Lys82){beta} cross-linked hemoglobin was bound. Plasma disappearance of low doses (0.31 µmol/kg) of native and cross-linked hemoglobins was monoexponential (half-life = 23 and 33 min, respectively). The volume of distribution (40 vs. 19 ml/kg) and plasma clearance (1.22 vs. 0.4 ml·min–1·kg–1) were higher for native than for cross-linked hemoglobin. Native and cross-linked human hemoglobins were found primarily in the liver, and not in the kidney, heart, lung, or spleen, mostly as degradation products. These pharmacokinetic findings suggest that the binding of hemoglobin to haptoglobin enhances its hepatocellular entry, clearance, and distribution.

organ disposition; liver transport; clearance



Address for reprint requests and other correspondence: K. S. Pang, Leslie Dan Faculty of Pharmacy, Univ. of Toronto, 19 Russell St., Toronto, ON, Canada M5S 2S2 (E-mail: ks.pang{at}utoronto.ca)




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
E. C. Y. Chow, L. Liu, N. Ship, R. H. Kluger, and K. S. Pang
Role of Haptoglobin on the Uptake of Native and {beta}-Chain [Trimesoyl-(Lys82){beta}-(Lys82){beta}] Cross-Linked Human Hemoglobins in Isolated Perfused Rat Livers
Drug Metab. Dispos., May 1, 2008; 36(5): 937 - 945.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.